Registered entities
BIOTHERYX, INC.
Reg. No. 260501342United States
Innovation
45 patent families (24 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 3,900 times.
| Year | Filings |
|---|---|
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 9 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 17 |
| 2022 | 22 |
| 2023 | 12 |
| 2024 | 13 |
| 2025 | 9 |
| 2026 | 2 |
Social engagement
Social engagement: 4.9K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Farallon Capital Management, MSD Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 36% |
| Private equity | 1 | 7% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 7 | 50% |
Recent activity
4 May 2026
Event
2026 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
12 Dec 2025
Event
San Antonio Breast Cancer Symposium 2025
17 Nov 2025
Milestone
regulatory